Login to Your Account

Sanofi Files for Lixisenatide OK In Japan, Awaits EU Decision

By Cormac Sheridan
Staff Writer

Wednesday, June 13, 2012
With its diabetes drug lixisenatide already undergoing regulatory review in Europe, Sanofi SA disclosed Monday, during the American Diabetes Association (ADA) meeting in Philadelphia, that it has now filed for regulatory approval in Japan.

To continue reading subscribe now to BioWorld Asia (formerly International)

Learn More about BioWorld Asia (formerly International)

Already a subscriber? Sign In or Buy now to activate your subscription